Blocking eIF5A Modification in Cervical Cancer Cells Alters the Expression of Cancer-Related Genes and Suppresses Cell Proliferation

These findings suggest a mechanistic rationale to immediately reposition two approved drugs for cancer treatment, offering a low-risk clinical opportunity to evaluate new therapeutic modalities for cancer treatment.